Skip to content

BELPHARMA

Active
Public limited companyfounded 199234 yrs activeAvenue Joseph Abras(BL) 54, 5001 Namur, BelgiumKBO/BCE: BE 0447.683.110
Summary

BELPHARMA has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €425,779 and a net result of €62,368. Equity is growing by ~9.9% per year across the filed fiscal years. Its solvency ranks better than 85% of 4188 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability82▲+3
Solvency98▼-2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35,000 at 30 days acceptable
Liquidity ample (current ratio 3.06 against 6.51 in 2024; short-term debt: 26.8% and cash: 50.6% of total assets), and 26.8% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 34 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
73.2%
Return on assets
10.7%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-05-2026, 66 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
66 d early
2024
66 d early
2023
58 d early
2022
60 d early
2021
11 d early
2020
44 d early
2019
63 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 53 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 25 June 1992, BELPHARMA was incorporated.1 Total assets went from EUR 349,601 in 2018 to EUR 581,313 in 2025 and headcount from 1 to 1.3 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€62,368▲ 45.9%
2024 · €42,745
Working capital
€320,675▼ 8.6%
2024 · €350,675
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€57,393▲ 3.2%€85,979▲ 49.8%€87,010▲ 1.2%€43,721▼ 49.8%€87,550▲ 100%
Net result€39,238▼ 1.6%€61,371▲ 56.4%€66,700▲ 8.7%€42,745▼ 35.9%€62,368▲ 45.9%
Equity€331,898▲ 7.9%€379,633▲ 14.4%€431,333▲ 13.6%€459,077▲ 6.4%€425,779▼ 7.3%
Total assets€432,095▲ 2.3%€480,464▲ 11.2%€509,261▲ 6.0%€527,828▲ 3.6%€581,313▲ 10.1%
Debt€100,197▼ 12.8%€100,831▲ 0.6%€77,928▼ 22.7%€68,750▼ 11.8%€155,534▲ 126%
Working capital€257,383▲ 4.8%€311,937▲ 21.2%€374,808▲ 20.2%€350,675▼ 6.4%€320,675▼ 8.6%
Staff (FTE)1.1▲ 120%0.8▼ 27.3%0.9▲ 12.5%0.6▼ 33.3%1.3▲ 117%
Result per fiscal year
Operating resultNet result
€0€25,000€50,000€75,000€100,000Operating result 2021: €57,393€57,393Net result 2021: €39,238€39,238Operating result 2022: €85,979€85,979Net result 2022: €61,371€61,371Operating result 2023: €87,010€87,010Net result 2023: €66,700€66,700Operating result 2024: €43,721€43,721Net result 2024: €42,745€42,745Operating result 2025: €87,550€87,550Net result 2025: €62,368€62,36820212022202320242025€0€25,000€50,000€75,000€100,000Operating result 2023: €87,010€87,000Net result 2023: €66,700€66,700Operating result 2024: €43,721€43,700Net result 2024: €42,745€42,700Operating result 2025: €87,550€87,500Net result 2025: €62,368€62,400202320242025
The operating result recovers in 2025; 2025 is 100% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €581,313
Fixed assets €105,104 ▼ 7.4%
Current assets €476,209 ▲ 14.9%
Equity and liabilities €581,313
Equity €425,779 ▼ 7.3%
Debt €155,534 ▲ 126%
Debt's share of the balance-sheet total rises from 13.0% to 26.8%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€109,181▲
2024 · €60,406
Cash flow
€83,999▲
2024 · €59,430
Current ratio
3.06▼
2024 · 6.51
Quick ratio
2.31▼
2024 · 4.65
Debt to equity
0.37▲
2024 · 0.15
ROE
14.6%▲
2024 · 9.3%
ROA
10.7%▲
2024 · 8.1%
Interest coverage
82.63▲
2024 · 19.44
Debt ≤ 1 year
€155,534▲
2024 · €63,610
Debt > 1 year
€0▼
2024 · €5,103
Income taxes
€24,951▲
2024 · -€1,476
Staff costs
€20,529▼
2024 · €37,224
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,324 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.4% went bankrupt
5.9% stopped otherwise
93% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,324 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 59 lines
Balance sheet Code20242025
Assets
Total assets20/58€527,828€581,313▲
Fixed assets21/28€113,543€105,104▼
Tangible fixed assets22/27€113,543€105,104▼
Land and buildings22€26,205€31,808▲
Plant, machinery and equipment23€71,453€60,448▼
Furniture and vehicles24€13,332€11,537▼
Other tangible fixed assets26€2,553€1,312▼
Current assets29/58€414,285€476,209▲
Stocks and contracts in progress3€118,194€117,223▼
Stocks30/36€118,194€117,223▼
Amounts receivable within one year40/41€61,757€62,541▲
Trade receivables40€58,986€62,510▲
Other amounts receivable41€2,771€31▼
Current investments50/53€35,000-
Cash at bank and in hand54/58€196,968€294,079▲
Deferred charges and accrued income490/1€2,365€2,365=
Equity and liabilities
Total equity and liabilities10/49€527,828€581,313▲
Equity10/15€459,077€425,779▼
Contributions10/11€123,947€123,947=
Capital10€123,947€123,947=
Issued capital100€123,947€123,947=
Reserves13€149,139€117,507▼
Non-distributable reserves130/1€12,395€12,395=
Legal reserve130€12,395€12,395=
Distributable reserves133€136,745€105,112▼
Profit (loss) carried forward14€185,991€184,325▼
Amounts payable17/49€68,750€155,534▲
Amounts payable after more than one year17€5,103€0▼
Financial debts170/4€5,103€0▼
Amounts payable within one year42/48€63,610€155,534▲
Current portion of amounts payable after more than one year42€6,069€5,103▼
Trade debts44€19,821€28,475▲
Suppliers440/4€19,821€28,475▲
Taxes, remuneration and social security45€9,491€13,061▲
Taxes450/3€6,696€10,562▲
Remuneration and social security454/9€2,796€2,500▼
Other amounts payable47/48€28,229€108,895▲
Accrued charges and deferred income492/3€38€0▼
Income statement Code20242025
Remuneration, social security and pensions62€37,224€20,529▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16,685€21,631▲
Other operating charges640/8€18,647€4,358▼
Gross operating margin9900€116,277€134,068▲
Operating profit (loss)9901€43,721€87,550▲
Financial income75/76B€655€1,091▲
Recurring financial income75€655€1,091▲
Financial charges65/66B€3,107€1,321▼
Recurring financial charges65€3,107€1,321▼
Profit (loss) for the period before taxes9903€41,268€87,319▲
Income taxes67/77-€1,476€24,951▲
Profit (loss) for the period9904€42,745€62,368▲
Profit (loss) for the period to be appropriated9905€42,745€62,368▲
Appropriation of the result
Profit (loss) to be appropriated9906€243,736€248,359▲
Profit (loss) brought forward from the previous period14P€200,991€185,991▼
Transfer from equity791/2-€94,000
Transfer to equity691/2€42,745€62,368▲
To other reserves6921€42,745€62,368▲
Profit to be distributed694/7€15,000€95,666▲
Return on contributions (dividend)694€15,000€95,666▲
Social balance
Average headcount (FTE)90870.6-

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€48,771€30,400€33,329€37,224€20,529▼ 44.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12,880€17,702€17,180€16,685€21,631▲ 29.6%
Other operating charges640/8€788€1,283€592€18,647€4,358▼ 76.6%
Gross operating margin9900€119,831€135,365€138,111€116,277€134,068▲ 15.3%
Operating profit (loss)9901€57,393€85,979€87,010€43,721€87,550▲ 100%
Financial income75/76B€26€0€317€655€1,091▲ 66.6%
Recurring financial income75€26€0€317€655€1,091▲ 66.6%
Financial charges65/66B€2,574€2,569€2,723€3,107€1,321▼ 57.5%
Recurring financial charges65€2,574€2,569€2,723€3,107€1,321▼ 57.5%
Profit (loss) for the period before taxes9903€54,844€83,411€84,604€41,268€87,319▲ 112%
Income taxes67/77€15,606€22,039€17,904-€1,476€24,951▲ 1,790%
Profit (loss) for the period9904€39,238€61,371€66,700€42,745€62,368▲ 45.9%
Profit (loss) for the period to be appropriated9905€39,238€61,371€66,700€42,745€62,368▲ 45.9%
Line20212022202320242025Change
Assets
Total assets20/58€432,095€480,464€509,261€527,828€581,313▲ 10.1%
Fixed assets21/28€97,671€84,876€67,696€113,543€105,104▼ 7.4%
Tangible fixed assets22/27€97,671€84,876€67,696€113,543€105,104▼ 7.4%
Land and buildings22€31,663€28,735€26,205€26,205€31,808▲ 21.4%
Plant, machinery and equipment23€26,838€22,938€16,947€71,453€60,448▼ 15.4%
Furniture and vehicles24€35,585€28,167€20,749€13,332€11,537▼ 13.5%
Other tangible fixed assets26€3,585€5,036€3,795€2,553€1,312▼ 48.6%
Current assets29/58€334,424€395,588€441,565€414,285€476,209▲ 14.9%
Stocks and contracts in progress3€101,919€111,142€119,711€118,194€117,223▼ 0.8%
Stocks30/36€101,919€111,142€119,711€118,194€117,223▼ 0.8%
Amounts receivable within one year40/41€39,316€44,746€114,676€61,757€62,541▲ 1.3%
Trade receivables40€38,751€42,611€112,198€58,986€62,510▲ 6.0%
Other amounts receivable41€565€2,135€2,478€2,771€31▼ 98.9%
Current investments50/53€80,000€15,000€25,000€35,000--
Cash at bank and in hand54/58€110,824€222,497€179,656€196,968€294,079▲ 49.3%
Deferred charges and accrued income490/1€2,365€2,202€2,522€2,365€2,365=
Equity and liabilities
Total equity and liabilities10/49€432,095€480,464€509,261€527,828€581,313▲ 10.1%
Equity10/15€331,898€379,633€431,333€459,077€425,779▼ 7.3%
Contributions10/11€123,947€123,947€123,947€123,947€123,947=
Capital10€123,947€123,947€123,947€123,947€123,947=
Issued capital100€123,947€123,947€123,947€123,947€123,947=
Reserves13€80,031€106,395€106,395€149,139€117,507▼ 21.2%
Non-distributable reserves130/1€12,395€12,395€12,395€12,395€12,395=
Legal reserve130€12,395€12,395€12,395€12,395€12,395=
Distributable reserves133€67,636€94,000€94,000€136,745€105,112▼ 23.1%
Profit (loss) carried forward14€127,920€149,291€200,991€185,991€184,325▼ 0.9%
Amounts payable17/49€100,197€100,831€77,928€68,750€155,534▲ 126%
Amounts payable after more than one year17€23,131€17,181€11,171€5,103€0▼ 100%
Financial debts170/4€23,131€17,181€11,171€5,103€0▼ 100%
Amounts payable within one year42/48€77,041€83,651€66,757€63,610€155,534▲ 145%
Current portion of amounts payable after more than one year42€5,892€5,951€6,009€6,069€5,103▼ 15.9%
Trade debts44€24,327€26,805€23,456€19,821€28,475▲ 43.7%
Suppliers440/4€24,327€26,805€23,456€19,821€28,475▲ 43.7%
Advances received on contracts in progress46€0-----
Taxes, remuneration and social security45€13,205€18,699€8,859€9,491€13,061▲ 37.6%
Taxes450/3€6,685€15,114€3,854€6,696€10,562▲ 57.7%
Remuneration and social security454/9€6,520€3,585€5,005€2,796€2,500▼ 10.6%
Other amounts payable47/48€33,616€32,197€28,432€28,229€108,895▲ 286%
Accrued charges and deferred income492/3€25€0-€38€0▼ 100%
Line20212022202320242025Change
Profit (loss) for the period9904€39,238€61,371€66,700€42,745€62,368▲ 45.9%
+ Depreciation and write-downs630€12,880€17,702€17,180€16,685€21,631▲ 29.6%
Operating cash flow (approximation)€52,118€79,074€83,880€59,430€83,999▲ 41.3%
Investment in fixed assets (approximation)--€4,907€0-€62,532-€13,193▲ 78.9%
Change in cash-€111,673-€42,841€17,312€97,111▲ 461%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-05
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
26-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
03-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Highest result since 2018net €66,700 ▲8.7%
Net result €66,700, the highest in the series.
01-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
20-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
17-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
29-05
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Weakest financial yearnet €19,331 ▼17.2%
Net result drops to €19,331, the lowest in the series; recovery starts the following year.
27-05
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
28-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
06-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 1992
seat establishment The establishment unit on the map
Ground area
1,417 m²
Building footprint
61 m²
Volume, LiDAR
490 m³
Parcel 92010C0093/00F002, Wallonia · tallest building 10.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Avenue Joseph Abras(BL) 54, 5001 Namur
Warehousing and support activities for transportation
since 19922.058.285.758
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92010C0093/00F002 Wallonia 1,417 m² 1 · 61 m² 10.4 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Namur2.058.285.758
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,860. 3,415 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded25-06-1992
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0447683110
Also 9925:BE0447683110
Registered 12-09-2025

Register as of 26 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.